| P/E (FY) | 18.5 | Sales (TTM) | SEK 9.66B |
| Earnings (TTM) | SEK 658.0M | ROE | 12.06% |
| Net Margin | 6.81% | ROIC | 14.84% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −5.93% |
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products across Europe, Asia, North America, and other markets through its Medical Solutions and Engineered Solutions segments. Its products include catheter balloons, breathing bags, pharmaceutical packaging, laboratory consumables, thermal-management materials, and EMI shielding gaskets, supported by capabilities such as injection and blow molding, extrusion, cleanroom production, assembly, and tool manufacturing. It serves medical technology, pharmaceutical, consumer electronics, telecom, automotive, and hygiene sectors. Formerly Nordiska Latexfabriken i Torekov AB, it was renamed Nolato in 1982; the company was founded in 1938 and is headquartered in Torekov, Sweden.
| Market Cap | — | Trading Days | 4109 |
| 52W High | 64.65 |
| 52W Low | 44.80 |
| % Off High | −25.75% |
| YTD | −19.61% | 1Y | −16.51% |
| 3Y | 19.01% | 5Y | −38.68% |
| 10Y | 173.02% | Since incept. (ann.) | 16.21% |
| Ann. Volatility (1Y) | 28.28% | Ann. Volatility (3Y) | 31.09% |
| Sharpe (1Y) | −0.52 | Sharpe (3Y) | 0.35 |
| Max Drawdown (1Y) | −26.43% | Max Drawdown (3Y) | −26.43% |
| Beta (3Y, vs SPY) | 0.35 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.15T | 53.2 |
| JNJ | JOHNSON & JOHNSON | $642.79B | 24.2 |
| ONC | BeOne Medicines Ltd. | $477.60B | 1739.3 |
| ABBV | AbbVie Inc. | $465.02B | 111.5 |
| MRK | Merck & Co., Inc. | $325.57B | 18.1 |
| AMGN | AMGEN INC | $212.16B | 27.6 |
| ABT | ABBOTT LABORATORIES | $186.84B | 28.8 |
| GILD | GILEAD SCIENCES, INC. | $166.77B | 19.8 |
| PFE | PFIZER INC | $143.91B | 18.6 |
| SYK | STRYKER CORP | $132.87B | 41.3 |
| BMY | BRISTOL MYERS SQUIBB CO | $129.88B | 18.4 |
| ISRG | INTUITIVE SURGICAL INC | $127.82B | 46.0 |
